Home > Financial Ratios > KWALITY PHARMACEUTICALS

KWALITY PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for KWALITY PHARMACEUTICALS
Please provide your vote to see the results

KWALITY PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 7.03-63.65475.4870.509.45

What is the latest Core EBITDA Growth ratio of KWALITY PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of KWALITY PHARMACEUTICALS is 7.03 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar20247.03
Mar2023-63.65
Mar2022475.48
Mar202170.50
Mar20209.45

How is Core EBITDA Growth of KWALITY PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 7.03
Positive
Mar2023 -63.65
Negative
Mar2022 475.48
574.44
Mar2021 70.5
646.03
Mar2020 9.45 -

Other Financial Ratios of KWALITY PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of KWALITY PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS ₹729.1 Cr -1% -19.1% 35.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,223.0 Cr -4.1% -9.8% 8.2% Stock Analytics
DIVIS LABORATORIES ₹152,610.0 Cr -2.9% -0.3% 63.8% Stock Analytics
CIPLA ₹119,067.0 Cr 0.1% 4.4% 2.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹102,744.0 Cr -1.3% -6.5% 19% Stock Analytics
DR REDDYS LABORATORIES ₹96,123.8 Cr -4% -5.9% -7.8% Stock Analytics


KWALITY PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS

-1%

-19.1%

35.9%

SENSEX

-0.8%

-1.6%

3.1%


You may also like the below Video Courses